Jump to start of content

ABIM call wait times may be longer than usual Expand/Collapse the ABIM alert.

Due to high volume, ABIM call wait times may be longer than usual. We know how busy you are, so we apologize for any inconvenience this may cause. You can always send us a message at abim.org/contact.

Coronavirus Updates Expand/Collapse the ABIM alert.

At ABIM we are actively monitoring the ongoing spread of coronavirus (COVID-19) and will post regular updates about any changes to scheduled assessments.
Scheduled for an assessment this year? ABIM is working with Pearson VUE to ensure your safety throughout your exam day. Learn more about what to expect at test centers.
Please follow the United States Centers for Disease Control and Prevention (CDC) for the most up-to-date information on the virus.

Breadcrumb trail:

ABIM Council

Expand All | Collapse All

Bruce Leff, MD, Chair

Bruce A. Leff, MDDr. Leff is a board certified internist and geriatrician and Professor of Medicine at the Johns Hopkins University School of Medicine in the Division of Geriatric Medicine and Gerontology. He holds a joint appointment in the Department of Health Policy and Management at the Johns Hopkins University Bloomberg School of Public Health, and in the Johns Hopkins School of Nursing, Department of Community and Public Health.

He is the Director of the Center on Aging and Health Program in Geriatric Health Services Research and the co-Director of the Elder House Call Program. His principal areas of health services research relate to the development, evaluation and dissemination of innovative models of health service delivery for older adults, issues related to the care of people with multiple chronic conditions, the development of quality indicators for home-based medical care, guideline development and case-mix issues. He is the author of more than 100 peer-reviewed publications and book chapters. Dr. Leff has a strong interest in health policy and is a recent health and aging policy fellow and has served on multiple National Quality Forum and Centers for Medicare & Medicaid Services Technical Expert Panels. Dr. Leff cares for patients in the acute, ambulatory and home settings.

The Chair-Elect of the American Board of Internal Medicine (ABIM) Council, Dr. Leff is also Chair of the ABIM Geriatric Medicine Board. He directs the medicine clerkship at the Johns Hopkins University School of Medicine and has received multiple awards for his teaching and mentorship. He is a member of the Board of Regents of the American College of Physicians, as well as past-President and current board member of the American Academy of Home Care Physicians.

Dr. Leff received his medical degree from the New York University School of Medicine and completed residency in primary care internal medicine at the Johns Hopkins Bayview Medical Center, and a fellowship in geriatric medicine and gerontology at the Johns Hopkins University School of Medicine, in Baltimore.

As of February 2020, Dr. Leff reported the following external relationships:

Dr. Leff holds a license on Hospital at Home, with income related to licensing technical materials to health systems, receiving royalties, paid to Johns Hopkins University.

Dr. Leff serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Alliance for Home Health Quality and Innovation, Member of Board of Directors, receiving reimbursement for travel.
  • American Academy of Home Care Physicians, Member of Board of Directors, receiving reimbursement for travel.
  • American Board of Medical Specialties, Vision Commission Member, receiving reimbursement for travel.
  • Ascension Health, Member of the Quality Committee to the Board of Directors, receiving reimbursement for travel.
  • American College of Physicians, Annals of Internal Medicine Editorial Board Member, without compensation.

Dr. Leff reported receiving grant funding for salary support, staff and project expenses from The Commonwealth Fund, the Alliance for Home Health Quality and Innovation, John A. Hartford Foundation, Patient-Centered Outcomes Research Institute, West Health Institute, and California Healthcare Foundation, all paid to Johns Hopkins University.

Dr. Leff reported receiving honoraria from the following for-profit healthcare companies: Honor, Dispatch Health, Medically Home, and Apple.

George M. Abraham, MD, MPH

George M. Abraham, MD, MPHDr. Abraham is Professor of Medicine at the University of Massachusetts Medical School, Chief of Medicine at Saint Vincent Hospital, Worcester, Massachusetts and Adjunct Professor at the Massachusetts College of Pharmacy and Health Sciences (MCPHS). He is board certified in Internal Medicine and Infectious Disease.

Currently, Dr. Abraham is a member of the American Board of Internal Medicine (ABIM) Council and Chair of the ABIM Infectious Disease Board. He serves as the Chair of the Board of Governors and a Regent of the American College of Physicians (ACP) and also serves on several of its committees. He also is Vice-Chair of the Board of Registration (Licensing) in Medicine, Massachusetts. Prior to this, he has served as a Trustee of the Massachusetts Medical Society, as President of the Worcester District Medical Society, as the Chief Medical Officer of the Central Massachusetts Independent Physician Association and Chair of the Board of Directors of the Health Foundation of Central Massachusetts.

He has received several awards including the Alpha Omega Alpha Volunteer Faculty Award and the Outstanding Primary Care Educator Award of University of Massachusetts Medical School; the Leadership Award of the Massachusetts chapter of the ACP; and the Phi Lambda Sigma honorary Membership, MCPHS, Worcester, Massachusetts, among others

His research interests include hepatitis C and B disease, travel medicine and infection control, as well as medication safety and systems improvement. He has authored several publications, abstracts and book chapters, and presented at national and international meetings.

Dr. Abraham earned his medical degree from the Christian Medical College, India, completed his residency and chief residency at Saint Vincent Hospital, and received his master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health.

As of August 2019, Dr. Abraham reported the following external relationships:

Dr. Abraham serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American College of Physicians, Member of Board of Regents, receiving reimbursement for travel expenses.

Olakunle Akinboboye, MD, MPH, MBA

Olakunle Akinboboye, MDDr. Akinboboye is board certified in Cardiovascular Disease and Sleep Medicine. He is the Clinical Professor of Cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is also the Medical Director of Queens Heart Institute/Laurelton Heart Specialist P.C. in Rosedale, Queens, New York.

Dr. Akinboboye is Chair of the American Board of Internal Medicine (ABIM) Cardiovascular Board and a member of the ABIM Council. He is also a member of the Association of Black Cardiologists (ABC) Executive Committee, where he serves as Chair of the Clinical Trials Committee. He also serves on the International Board of Governors of the American College of Cardiology (Liaison for Africa). He served as the President of the ABC from 2012 to 2014.

He received a humanitarian award from the College of Medicine at University of Ibadan in Nigeria in 2005 for his ongoing efforts to spread expertise in the techniques of cardiopulmonary resuscitation in Nigeria. He also received an award from ABC for his dedicated service as a board member from 1999 to 2005.

Dr. Akinboboye received his medical degree from the College of Medicine at the University of Ibadan. He completed his internal medicine residency and part of his cardiology fellowship at the Nassau County Medical Center, State University of New York at Stony Brook. He subsequently moved to Columbia University, where he completed his fellowship in cardiology with one year of dedicated training in nuclear cardiology and another year of training in advanced echocardiography. Dr. Akinboboye obtained a master's degree in public health from Columbia University. He also received a master’s degree in business administration from Columbia Business School.

As of May 2020, Dr. Akinboboye reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Queens Heart Institute, from the following companies:

  • AstraZeneca, for a study of the effects of exenatide in lowering cardiovascular events in patients with type 2 diabetes mellitus (EXSCEL).
  • Novartis, for a study of the effectiveness of angiotensin-neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF).

Attendance at investigators’ meetings, with compensation for travel expenses from the following companies:

  • Cytokinetics, for a study to evaluate the effect of treatment with omecamtiv mecarbil compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing following 20 weeks of treatment with omecamtiv mecarbil or placebo.

Ashok Balasubramanyam, MD

Ashok Balasubramanyam, MDDr. Balasubramanyam, a board certified internist and endocrinologist, is Professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, Vice President for Academic Integration and Senior Associate Dean for Academic Affairs at Baylor College of Medicine, Houston. His academic career involves basic and translational research in diabetes and metabolic diseases, education (including service as past director of the endocrine fellowship program and current director of Baylor’s Clinical Scientist Training Program), and clinical practice as an internist and endocrine consultant.

Currently, Dr. Balasubramanyam serves as a member of the American Board of Internal Medicine (ABIM) Council and the Chair of the ABIM Endocrinology Disease, and Metabolism Board. He is a past president of the Association of Program Directors in Endocrinology and Metabolism.

Dr. Balasubramanyam earned his undergraduate degree at Yale University and his medical degree at St. John’s Medical College, Bangalore, India. He completed residency training and was Chief Resident at Baylor College of Medicine, and completed clinical and research fellowship training in endocrinology at the Massachusetts General Hospital, Boston.

As of August 2019, Dr. Balasubramanyam reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed below:

  • UpToDate, receiving compensation for authorship on ketosis-prone diabetes.

Dr. Balasubramanyam serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Harris County Medical Society, Board Member, without compensation.

Laura Evans, MD, MSC

Laura E. Evans, MD

Dr. Evans is an Associate Professor of Medicine at New York University (NYU) School of Medicine, the Medical Director of Critical Care and Associate Chief of Medicine at Bellevue Hospital. She also serves as the Associate Program Director for the NYU Pulmonary and Critical Care Fellowship Program. She is board certified in Internal Medicine, Pulmonary, Critical Care Medicine and Hospice and Palliative Medicine. Her interests focus on education, patient safety and quality improvement in the intensive care unit.

She joined the Critical Care Medicine Board of the American Board of Internal Medicine in 2014. She has served as the Chair of the Internal Medicine Section of the Society of Critical Care Medicine and served on the Guidelines Oversight Committee of the American College of Chest Physicians. She received the Darlene Buczak Award for Innovations in Medical Education from the Association of Pulmonary and Critical Care Medicine Program Directors.

Dr. Evans earned her medical degree at the University of Michigan and completed her internal medicine residency at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a master of science degree in epidemiology at the University of Washington.

As of November 2019, Dr. Evans reported the following external relationships:

Work as an author or editor for following company, with compensation as listed:

  • Elsevier, receiving compensation for authorship for textbook for medical students.

Dr. Evans serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Society of Critical Care Medicine, Surviving Sepsis Campaign Guidelines, Co-Chair, Council, Member, receiving reimbursement for travel expenses.

Salahuddin Kazi, MD

Dr. Kazi, a board certified internist and rheumatologist, is the Vice Chair of Education for the Department of Internal Medicine and a Professor of Medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center in Dallas, Texas. He is also the Director of the Internal Medicine Residency Training Program at UT Southwestern. Dr. Kazi is the Chair of the American Board of Internal Medicine Rheumatology Board. Dr. Kazi previously served as the Chair of the Registries and Health Information Technology Committee of the American College of Rheumatology overseeing the development of the RISE registry. Dr. Kazi continues to lead efforts in rheumatology to promote improvement in the delivery of healthcare through the principles of co-production.

Dr. Kazi earned his medical degree from Dow Medical College in Karachi, Pakistan, and completed his residency, chief residency and fellowship in rheumatology at the University of Texas Health Science Center in Houston.

As of February 2019, Dr. Kazi reported no external relationships.

Dr. Kazi serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Arthritis Foundation, serving as a consultant, with funding paid to the UT Southwestern Medical Center.

Tommye Lambert, D.Min. M.Div

Tommye Lambert, MDivDr. Lambert is the mother and life-long caregiver to her daughter, Amy Crews, who passed away at age twenty-eight from complications associated with cystic fibrosis and lung transplantation. During that time, she interacted with pulmonary care clinicians at five centers, including critical care and transplant teams. She is a leader in the patient and caregiver community providing training and facilitating discussions focused on assisting in improved patient care through patient-doctor communication and collaboration. She serves as a public/patient member on the American Board of Internal Medicine (ABIM) Council.

Dr. Lambert is active with the National Cystic Fibrosis Foundation (CFF). She serves on the Palliative Care Guidelines Committee, as a CFF MiniCon panelist, as a parent/patient advocate, as a legislative forum volunteer, and has been active in annual fundraising activities for CFF for more than 30 years. Dr. Lambert advocates for organ donation by speaking and fundraising through Legacy of Hope, formerly Alabama Organ Center.

After her daughter died, Dr. Lambert launched a ministry and blog, Liveandproclaim.com to encourage those walking through difficult circumstances. She also serves on the Advisory Board of Shepherd’s Fold, a re-entry program for those transitioning from incarceration.

Professionally, Lambert works as a speaker, writer, minister, and adjunct professor. She teaches in the religion department at Judson College in Marion, Alabama.

Dr. Lambert earned her doctorate in ministry and a master's degree in divinity from Beeson Divinity School, Samford University in Birmingham. She earned a bachelor's degree in medical technology from the University of Southern Mississippi in Hattiesburg, MS.

As of March 2020, Ms. Lambert reported no external relationships.

Julianne Morath, RN

Julianne MorathMs. Morath is an international consultant in patient safety and healthcare quality leadership. Her work focuses on creating cultures of safety and designing reliability into clinical practice and the structures and mechanisms that support patient care. She is noted for her work in promoting workforce engagement and interdisciplinary alignment, and patient, family, and community advocacy.

Ms. Morath has served in executive positions and academic appointments at the University of Cincinnati, Brown University and Vanderbilt University Academic Medical Centers. Her executive experience also includes Children's Hospitals and Clinics of Minnesota; Allina Health System, and founding the Hospital Quality Institute, supporting more than 400 California hospitals and health systems. She is a founding and current member of the Lucian Leape Institute of the National Patient Safety Foundation (NPSF) and serves as faculty at the Institute for Healthcare Improvement.

Ms. Morath served as a member of the Board of Commissioners of The Joint Commission. She holds current appointments on multiple governing and advisory boards, including the Collaborative for Accountability and Improvement, Center for Scholarship Quality and Patient Safety, University of Washington School of Medicine; MedStar Quality and Patient Safety Institute Advisory Board; and Board of Trust, Virginia Mason Medical Center and Health Care System.

She was the inaugural recipient of the John Eisenberg Award for Individual Lifetime Achievement in Patient Safety from the National Quality Forum and The Joint Commission. In 2018 she received the Beau Biden Humanitarian Award from the Patient Safety Movement Foundation. Of more than 50 published works, she has authored two books: Do No Harm and The Quality Advantage, and contributed to six major reports from the Lucian Leape Institute on topics of transforming healthcare.

Ms. Morath earned her master's in Nursing from the University of California, San Francisco and her BSN from the University of Michigan, Ann Arbor.

As of February 2020, Ms. Morath reported the following external relationships:

Morath serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Institute for Healthcare Improvement, Lucian Leape Institute, founding and current member, receiving reimbursement for travel expenses.
  • Ms. Morath also reported work as a consulting member of a workgroup in patient safety in dentistry at the American Dental Association.

Michael E. Nelson, MD

Michael E. Nelson, MDDr. Nelson is a practicing physician in Shawnee Mission, Kansas. He is a member of the staff of Shawnee Mission Medical Center, where he has previously served as the Chairman of the Department of Internal Medicine. He is currently the Medical Director of the Sleep Laboratory. His certifications from the American Board of Internal Medicine (ABIM) include Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He also holds a certification in Sleep Medicine from the American Board of Sleep Medicine.

Currently, Dr. Nelson serves as a member of the ABIM Council. He is also a member of the Education Committee and the Clinical Practice Committee of the American Thoracic Society (ATS). He has been an active participant in the educational programs of the American College of Physicians and the American College of Chest Physicians (ACCP). Dr. Nelson serves as the Alternate Advisor to the American Medical Association's Current Procedural Terminology Committee for the ACCP and the ATS.

Dr. Nelson earned his medical degree at the University of Kansas School of Medicine. He completed his residency and chief residency in internal medicine, as well as a fellowship in pulmonary and critical care medicine, at the Department of Medicine at the University of Kansas.

As of March 2020, Dr. Nelson reported the following external relationships:

Dr. Nelson serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, Member, Board of Regents, without compensation.
  • American Thoracic Society, Member, Clinical Practice Committee, without compensation.
  • Medical Education Resources, lectures on pulmonary disease and sleep medicine, receiving reimbursement for travel expenses.

Jane E. Onken, MD

Jane E. Onken, MDDr. Onken is an Associate Professor of Medicine, Division of Gastroenterology at Duke University Medical Center. She is Director of the Inflammatory Bowel Disease clinic at Duke and on faculty at the Duke Clinical Research Institute. She is board certified in Gastroenterology.

Dr. Onken is Chair of the American Board of Internal Medicine (ABIM) Gastroenterology Board and a member of the ABIM Council. She recently completed a three-year term as Chair of the Education and Training Committee of the American Gastroenterological Association (AGA). During that term, she served on the AGA’s Leadership Cabinet, the Maintenance of Certification Task Force, and the board of the Academy of Educators. She has chaired the AGA Training Subcommittee and has been a member of the Graduate Training Examination Subcommittee. In 2013, she was selected to join the multi-society Oversight Working Network Committee, a group that designed the Entrustable Professional Activities currently in use by training programs in gastroenterology. At Duke, she was recently elected for a fourth term to the University's Academic Council and has served on the Executive Committee of the Academic Council. Dr. Onken is a former program director for the Duke Gastroenterology Fellowship program. She is a member of the Leadership Board of the Triangle Chapter of the Crohn’s and Colitis Foundation of America (CCFA) and is a recipient of the CCFA Premier Physician Award.

Dr. Onken received her undergraduate degree from Smith College and attended the George Washington University School of Medicine. She completed her house staff training in internal medicine at Duke University, followed by fellowship training in gastroenterology. She received a master’s degree in health sciences from Duke in 2005.

As of September 2019, Dr. Onken reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Duke University, from the following company:

  • Boehringer Ingelheim, for a phase II/III clinical trial in patients with moderate to severe ulcerative colitis.
  • Janssen, for phase I clinical trial of ustekinumab in Crohn's disease.
  • Seres Therapeutics, for a clinical trial investigating fecal replacement for patients with mild-to-moderate ulcerative colitis.

Work funded by educational grants from industry, paid to Duke University, from the following companies:

  • Takeda, to create two dinner symposia updating community providers on irritable bowel disease, and two podcasts related to irritable bowel disease.

Dr. Onken serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Gastroenterological Association, Special Section Editor of Education and Training, receiving honoraria.
  • Crohn’s and Colitis Foundation, Triangle Patient Education Day Planning Committee Member and Speaker, without compensation.

John J. Oppenheimer, MD

Dr. Oppenheimer is the Director of Clinical Research at Pulmonary and Allergy Associates as well as Clinical Professor of Medicine at University of Medicine and Dentistry New Jersey-Rutgers. He is board certified in Internal Medicine and Allergy and Immunology. He trained and was on faculty at the National Jewish Center in Denver Colorado. Dr. Oppenheimer has participated in over 100 clinical studies with over 200 publications. He serves as the Associate Editor of the Annals of Allergy Asthma and Immunology, co-section editor of Current Reports of Allergy and Immunology, Current Opinion of Allergy and Immunology and serves as a reviewer for several journals including the Journal of Allergy and Clinical Immunology and JAMA. He also serves as a member of the American Board of Internal Medicine Council.

He is the past Chairman of the ADT section as well as the Interest Section Coordinating Committee of the American Academy of Allergy, Asthma and Immunology, serves on the Joint Task Force of the Practice Parameter Committee for Allergy Immunology, the writing committee of the cough guidelines committee for the American College of Chest Physicians, a voting member of Physician Consortium for Performance Improvement and member of the measures development for atopic dermatitis, was on the Board of Directors of the American Board of Allergy and Immunology (ABAI) 2010-2015 and is the past Chairman of the ABAI. He has focused his career on guideline development and has been actively involved in measurement development in the field of allergy and immunology.

As of July 2019, Dr. Oppenheimer reported the following external relationships:

Preclinical research, with funding for salary support, from the following companies:

  • AbbVie, for evaluation of potential anaphylaxis.

Funding for clinical trial expenses and staff, paid to Pulmonary and Allergy Associates, P.A., from the following companies:

  • Genentech, for a study on long-term safety of omalizumab.

Attendance at investigators’ meetings, with compensation for travel expenses from the following companies:

  • Novartis, regarding omalizumab.

Service on data and safety monitoring boards for the following companies, with and honoraria:

  • AstraZeneca, chair of tezepelumab adjudication committee.
  • GlaxoSmithKline, regarding mepolizumab.
  • Sangamo, regarding dupilumab.

Service on a research-related expert panel or advisory board for the following companies, without compensation:

  • GlaxoSmithKline, for advising on a closed triple pivotal trial design.

Rudolph A. Rodriguez, MD

Dr. Rodriguez, a board certified internist and nephrologist, is the Director of the Hospital & Specialty Medicine Service Line at the VA Puget Sound Health Care System and a Professor and Vice Chair of the Department of Medicine at the University of Washington. As a clinician scholar, his academic career focused on Nephrology Fellowship Education along with scholarly work on issues related to vulnerable populations.

Dr. Rodriguez serves as a member of the American Board of Internal Medicine Nephrology Board. He is the Chair of the Veteran Affairs Nephrology Field Advisory Committee. He served on the American Society of Nephrology Training Program Director’s Executive Committee.

Dr. Rodriguez attended Stanford University and earned his medical degree at the Charles Drew/UCLA Medical Education Program at the University of California, Los Angeles. He completed his internal medicine residency at California Pacific Medical Center, and his nephrology fellowship training at the University of California, San Francisco.

As of July 2020, Dr. Rodriguez reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Dr. Rodriguez serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Veterans Affairs, serving as Chair, of the Field Advisory Committee, without compensation.

Robert D. Siegel, MD

Robert D. Siegel, MDDr. Siegel, a board certified internist, hematologist and medical oncologist is the Oncology Program Director for the Bon Secours St. Francis Health System in Greenville, South Carolina. Prior to his appointment to program leadership at St. Francis, Dr. Siegel had been a community based oncologist with particular interest in quality improvement initiatives and cancer care delivery research.

Dr. Siegel has served the ABIM as a member of the Medical Oncology Exam Writing Committee and is currently a member of the Specialty Board in Medical Oncology. In July, 2015, he was elected to serve on the ABIM Board of Directors. He has previously served as the Co-Chair of the Quality of Care Subcommittee for the NCI Community Cancer Centers Program (NCCCP) and is currently on the Executive Committee for SCOR (Southeast Consortium for Oncology Research).

Dr. Siegel earned his medical degree at the Columbia University College of Physicians and Surgeons and did his internal medicine training at Barnes Hospital/Washington University in St. Louis. He completed his fellowship training in medical oncology and hematology at the Dana Farber Cancer Institute/ Brigham and Women's Hospital/ Harvard University.

As of February 2020, Dr. Siegel reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Bon Secours St. Francis Hospital, from the following companies:

  • Bristol-Myers Squibb, for a lung cancer clinical trial, kidney cancer clinical trial, and for a non-Hodgkin lymphoma clinical trial.
  • Cancer Insight, for a melanoma clinical trial.
  • Merck, for clinical trials for head and neck carcinoma, breast carcinoma, extensive stage small lung cancer, and stomach cancer clinical trials.
  • Mirati Therapeutics, for a clinical trial for solid tumors.
  • Biodesix, for an observational study assessing the clinical effectiveness of validating immunotherapy tests in subject with non-small cell lung cancer.
  • CerRX Inc., for a Phase II trial of intravenous fenretinide emulsion for patients with relapsed/refractory peripheral T-cell lymphomas.
  • Boston Biomedical, for a Phase II trial of metastatic pancreatic ductal adenocarcinoma.
  • GRAIL, Inc., for a trial of use deep sequencing of circulating cell-free nucleic acids to develop assays to detect cancer early in blood.
  • Pharmatech, for a trial of the treatment of cutaneous T-cell lymphoma.
  • Altor Bioscience, for two studies on advanced and metastatic non-small lung cancer.
  • AstraZeneca, for a study of durvalumab +tremelimumab combination therapy or durvalumab monotherapy in advanced solid malignancies.
  • Calithera Biosciences, for a study of advanced or metastatic renal cell carcinoma.
  • Galera Therapeutics, for a study of locally advanced, non-metastatic squamous cell carcinoma of the oral cavity or oropharynx, and for a study of incidence of esophagitis in in patients receiving chemoradiotherapy for lung cancer.
  • Apollomics, for a study of non-small cell lung cancer with c-Met EXON 14 skip mutations and c-Met dysregulation advanced solid tumors.
  • Exact Science, for blood sample collection to evaluate biomarkers in subjects with untreated hematologic malignancies.
  • Strata Oncology, for a study of molecular profiling of biospecimens from cancer patients to assist in screening for clinical trial enrollment.
  • Arcus, for a Phase 1b study to evaluate the safety and clinical activity of AB122 in biomarker-selected participants with advanced solid tumors.
  • Summit, for a study on patients with solid tumors with somatic human epidermal growth factor receptor (EGFR, HER2, HER3) mutations of EGFR gene amplification.

Dr. Siegel serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Society for Clinical Oncology, Past Chair of Quality Oncology Practice Initiative Certification Oversight Committee, Chair Elect Quality Oncology Practice Initiative Steering Group, Quality Care Committee Member, and International Quality Task Force Member, receiving reimbursement for travel expenses.
  • Guardian Research Network, Board of Directors, without compensation.
  • Southeastern Health Partners, Board of Directors, without compensation.

Lynn T. Tanoue, MD, MBA

Lynn T. Tanoue, MDDr. Tanoue is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine. She is Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She directs the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, co­directs the Yale Thoracic Oncology Program, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.

Dr. Tanoue is a member of the American Board of Internal Medicine's (ABIM) Council, and is currently chair of the American Thoracic Society Thoracic Oncology Assembly. She has served in leadership roles in the American College of Chest Physicians and the National Association for the Medical Direction of Respiratory Care. She serves on numerous committees at her home institutions, including as a member of the governing Board of Yale Medicine, and as immediate past-president of the medical staff of Yale New Haven Hospital. Dr. Tanoue is currently President of the Board of Directors of the Yale Medical Symphony Orchestra.

Dr. Tanoue received her bachelor’s degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital. Dr. Tanoue received her masters in business administration from Yale School of Management.

As of May 2020, Dr. Tanoue reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • Elsevier, receiving compensation as an Editor of “Year Book of Pulmonary Disease.”

Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Chair, Thoracic Oncology Assembly, receiving reimbursement for travel expenses.

Asher A. Tulsky, MD, Chair-elect

Asher A. Tulsky, MDDr. Tulsky is a board certified internist. He is Associate Professor of Medicine at the Boston University School of Medicine and Associate Chief of Education in the section of General Internal Medicine. His career has focused on postgraduate medical education, and he is currently Director of Resident Development at Boston Medical Center.

Previously, he was Associate Program Director at the University of Pittsburgh Internal Medicine Residency program, directed their community-based residency program, established and directed the International Scholars Program for gifted and accomplished international medical graduates pursuing academic medicine careers and was the principal consultant in a collaboration between the University of Pittsburgh and the Teine Keijinkai Hospital in Sapporo, Japan, in establishing a U.S.-modeled internal medicine residency program.

A member of the American Board of Internal Medicine's (ABIM) Council, Dr. Tulsky is also Chair of the ABIM Internal Medicine Specialty Board and served for eight years on the ABIM Internal Medicine Board Exam Committee. He is also an active member of the Association of Program Directors of Internal Medicine.

Dr. Tulsky earned his medical degree from the Chicago Medical School, completed internal medicine residency training at the Michael Reese Hospital and Medical Center in Chicago and fellowship in general internal medicine at the University of Rochester School of Medicine and Dentistry.

As of July 2019, Dr. Tulsky reported the following external relationships:

Dr. Tulsky serves in a significant role with the following organization, receiving reimbursement or compensation as listed:

  • Alliance for Academic Internal Medicine, Program Planning Committee, without compensation.

Mark M. Udden, MD

Mark M. Udden, MD Dr. Udden, a board-certified hematologist and internist, is Chief of Benign Hematology and Professor of Medicine at Baylor College of Medicine in Houston, Texas. He is Chief of Hematology at the Ben Taub General Hospital and Harris Health Smith Clinic. He is also an Attending Physician in the Baylor Clinic and consults at Baylor Saint Luke’s Medical Center and the Texas Children’s Hospital Pavilion for Women. He has a special interest in sickle cell disease and hematology of pregnancy. He also co-chairs the second-year medical student course in hematology/oncology and has an active teaching role for resident and fellowship training at Baylor.

He has served at Baylor as Core Clerkship Director for Internal Medicine from 1990 to 2007 and Chairman of the Longitudinal Ambulatory Care Experience course from 1994 to 1999. He was an Adjunct Assistant then Associate Professor in the Biomedical Engineering Department at Rice University from 1983 until 1992.

Dr. Udden is Chair of the American Board of Internal Medicine (ABIM) Hematology Board. He is also Chair of the ABIM Hematology Board Exam Committee. He is a fellow of the American College of Physicians. At Baylor, he has received numerous teaching awards including the Barbara and Corbin J. Robertson, Jr. Presidential Award for Excellence in Education in 2008 and the Master Clinician Lifetime Award in 2013.

He received his undergraduate degree from the Massachusetts Institute of Technology and his medical degree from The University of Texas Southwestern Medical School. He completed his residency in internal medicine and a fellowship in hematology at Baylor College of Medicine.

As of May 2020, Dr. Udden reported the following external relationships:

Dr. Udden serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Society of Hematology, serving as a guest speaker, receiving reimbursement for travel expenses and honoraria.